KOD compared with ACAD: revenue, margins and what each company keeps, and the suppliers and customers both name

KODKodiak Sciences Inc.

Mkt capRevenueRevenue

ACADAcadia Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

KODKodiak Sciences Inc.

ACADAcadia Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

KOD, solidACAD, dashed

Supply-chain overlap

Revenue flow

KOD: latest quarter not drawable.Method ›

KODKodiak Sciences Inc.

100.68▲+0.28%· post 99.34

Mkt cap$6.2BRevenue—Revenue—

ACADAcadia Pharmaceuticals Inc

20.59▼−0.81%· post 20.59

ClosedOct 30 '26

Mkt cap$3.5BRevenue$308MQ2 FY26Revenue$1.1BFY25

Compare

ClosedOct 30 '26

KODKodiak Sciences Inc.

ACADAcadia Pharmaceuticals Inc

100.68▲+0.28%post 99.34

Price

20.59▼−0.81%post 20.59

$6.2B

Mkt cap

$3.5B

—

Revenue

$308MQ2 FY26

—

Revenue

$1.1BFY25

KOD100.68▲+0.28%vsACAD20.59▼−0.81%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only KOD 1

—Lonzaunlistedsupplier

Shared 0

No shared counterparties.

Only ACAD 4

STOKStoke Therapeuticssupplier

—Neurenunlistedsupplier

—Single wholesale distributorunlistedcustomer

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Third party distributors

unlistedcustomer